{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:58:04Z","timestamp":1772254684367,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PPP Allowance","award":["LSHM19027"],"award-info":[{"award-number":["LSHM19027"]}]},{"name":"PPP Allowance","award":["LSHM21018"],"award-info":[{"award-number":["LSHM21018"]}]},{"name":"Health\u223cHolland, Top Sector Life Sciences & Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Genomic instability is a hallmark of cancer, leading to many somatic alterations. Identifying which alterations have a system-wide impact is a challenging task. Nevertheless, this is an essential first step for prioritizing potential biomarkers. We developed CIBRA (Computational Identification of Biologically Relevant Alterations), a method that determines the system-wide impact of genomic alterations on tumor biology by integrating two distinct omics data types: one indicating genomic alterations (e.g. genomics), and another defining a system-wide expression response (e.g. transcriptomics). CIBRA was evaluated with genome-wide screens in 33 cancer types using primary and metastatic cancer data from the Cancer Genome Atlas and Hartwig Medical Foundation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We demonstrate the capability of CIBRA by successfully confirming the impact of point mutations in experimentally validated oncogenes and tumor suppressor genes (0.79 AUC). Surprisingly, many genes affected by structural variants were identified to have a strong system-wide impact (30.3%), suggesting that their role in cancer development has thus far been largely under-reported. Additionally, CIBRA can identify impact with only 10 cases and controls, providing a novel way to prioritize genomic alterations with a prominent role in cancer biology. Our findings demonstrate that CIBRA can identify cancer drivers by combining genomics and transcriptomics data. Moreover, our work shows an unexpected substantial system-wide impact of structural variants in cancer. Hence, CIBRA has the potential to preselect and refine current definitions of genomic alterations to derive more nuanced biomarkers for diagnostics, disease progression, and treatment response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>The R package CIBRA is available at https:\/\/github.com\/AIT4LIFE-UU\/CIBRA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btae384","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:45:33Z","timestamp":1725522333000},"page":"ii37-ii44","source":"Crossref","is-referenced-by-count":5,"title":["CIBRA identifies genomic alterations with a system-wide impact on tumor biology"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8521-4408","authenticated-orcid":false,"given":"Soufyan","family":"Lakbir","sequence":"first","affiliation":[{"name":"Bioinformatics Section, Department of Computer Science, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands"},{"name":"Translational Gastrointestinal Oncology Group, Department of Pathology, Netherlands Cancer Institute , Amsterdam, The Netherlands"},{"name":"AI Technology for Life group, Department of Information and Computing Sciences and Department of Biology, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1329-3517","authenticated-orcid":false,"given":"Caterina","family":"Buranelli","sequence":"additional","affiliation":[{"name":"Bioinformatics Section, Department of Computer Science, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands"},{"name":"Translational Gastrointestinal Oncology Group, Department of Pathology, Netherlands Cancer Institute , Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-3130","authenticated-orcid":false,"given":"Gerrit A","family":"Meijer","sequence":"additional","affiliation":[{"name":"Translational Gastrointestinal Oncology Group, Department of Pathology, Netherlands Cancer Institute , Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-4930","authenticated-orcid":false,"given":"Jaap","family":"Heringa","sequence":"additional","affiliation":[{"name":"Bioinformatics Section, Department of Computer Science, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-5521","authenticated-orcid":false,"given":"Remond J A","family":"Fijneman","sequence":"additional","affiliation":[{"name":"Translational Gastrointestinal Oncology Group, Department of Pathology, Netherlands Cancer Institute , Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-7174","authenticated-orcid":false,"given":"Sanne","family":"Abeln","sequence":"additional","affiliation":[{"name":"Bioinformatics Section, Department of Computer Science, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands"},{"name":"AI Technology for Life group, Department of Information and Computing Sciences and Department of Biology, Utrecht University, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"2024090414000972700_btae384-B1","doi-asserted-by":"crossref","first-page":"i988","DOI":"10.1093\/bioinformatics\/bty636","article-title":"iTOP: inferring the topology of omics data","volume":"34","author":"Aben","year":"2018","journal-title":"Bioinformatics"},{"key":"2024090414000972700_btae384-B2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"2024090414000972700_btae384-B3","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1093\/bioinformatics\/btz501","article-title":"OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers","volume":"35","author":"Arnedo-Pac","year":"2019","journal-title":"Bioinformatics"},{"key":"2024090414000972700_btae384-B4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"2024090414000972700_btae384-B5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jcp-2022-208655","article-title":"GTF2I mutation in micronodular thymoma with lymphoid stroma","volume":"77","author":"Bille","year":"2022","journal-title":"J Clin Pathol"},{"key":"2024090414000972700_btae384-B6","doi-asserted-by":"crossref","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"2024090414000972700_btae384-B7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13059-022-02705-y","article-title":"Widespread redundancy in-omics profiles of cancer mutation states","volume":"23","author":"Crawford","year":"2022","journal-title":"Genome Biol"},{"key":"2024090414000972700_btae384-B8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cells10010046","article-title":"Tumor suppressors having oncogenic functions: the double agents","volume":"10","author":"Datta","year":"2020","journal-title":"Cells"},{"key":"2024090414000972700_btae384-B9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12920-022-01214-y","article-title":"Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics","volume":"15","author":"Doig","year":"2022","journal-title":"BMC Med Genomics"},{"key":"2024090414000972700_btae384-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04002-7","article-title":"Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice","volume":"5","author":"Giorgetti","year":"2022","journal-title":"Commun Biol"},{"key":"2024090414000972700_btae384-B11","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1093\/nar\/gks743","article-title":"Functional impact bias reveals cancer drivers","volume":"40","author":"Gonzalez-Perez","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2024090414000972700_btae384-B12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N Engl J Med"},{"key":"2024090414000972700_btae384-B13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/1078-0432.CCR-13-1943","article-title":"Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients","volume":"20","author":"Guinney","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2024090414000972700_btae384-B14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"2024090414000972700_btae384-B15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2024090414000972700_btae384-B16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/bjc.2017.37","article-title":"Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer","volume":"116","author":"Jones","year":"2017","journal-title":"Br J Cancer"},{"key":"2024090414000972700_btae384-B17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Reports"},{"key":"2024090414000972700_btae384-B18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N Engl J Med"},{"key":"2024090414000972700_btae384-B19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2022.09.034","article-title":"Tumor break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer","volume":"177","author":"Lakbir","year":"2022","journal-title":"Eur J Cancer"},{"key":"2024090414000972700_btae384-B20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"2024090414000972700_btae384-B21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"2024090414000972700_btae384-B22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.bjc.6605177","article-title":"KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer","volume":"101","author":"Loupakis","year":"2009","journal-title":"Br J Cancer"},{"key":"2024090414000972700_btae384-B23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2024090414000972700_btae384-B24","doi-asserted-by":"crossref","first-page":"20785","DOI":"10.18632\/oncotarget.4750","article-title":"Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance","volume":"6","author":"Morkel","year":"2015","journal-title":"Oncotarget"},{"key":"2024090414000972700_btae384-B25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"key":"2024090414000972700_btae384-B26","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2024090414000972700_btae384-B27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.3586","article-title":"Protein-structure-guided discovery of functional mutations across 19 cancer types","volume":"48","author":"Niu","year":"2016","journal-title":"Nat Genet"},{"key":"2024090414000972700_btae384-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41525-019-0107-6","article-title":"Spontaneous mutations in the single TTN gene represent high tumor mutation burden","volume":"5","author":"Oh","year":"2020","journal-title":"NPJ Genom Med"},{"key":"2024090414000972700_btae384-B29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molmed.2023.03.007","article-title":"Cancer driver mutations: predictions and reality","volume":"29","author":"Ostroverkhova","year":"2023","journal-title":"Trends Mol Med"},{"key":"2024090414000972700_btae384-B30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nmeth.4364","article-title":"Comparison of algorithms for the detection of cancer drivers at subgene resolution","volume":"14","author":"Porta-Pardo","year":"2017","journal-title":"Nat Methods"},{"key":"2024090414000972700_btae384-B31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/btg148","article-title":"Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values","volume":"19","author":"Pounds","year":"2003","journal-title":"Bioinformatics"},{"key":"2024090414000972700_btae384-B32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","article-title":"Pan-cancer whole-genome analyses of metastatic solid tumours","volume":"575","author":"Priestley","year":"2019","journal-title":"Nature"},{"key":"2024090414000972700_btae384-B33","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1158\/1055-9965.EPI-20-0074","article-title":"Pitfalls in cancer biomarker discovery and validation with emphasis on circulating tumor DNA","volume":"29","author":"Ren","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024090414000972700_btae384-B34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1158\/2159-8290.CD-17-0909","article-title":"MACROD2 haploinsufficiency impairs catalytic activity of PARP1 and promotes chromosome instability and growth of intestinal tumors","volume":"8","author":"Sakthianandeswaren","year":"2018","journal-title":"Cancer Discov"},{"key":"2024090414000972700_btae384-B35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"2024090414000972700_btae384-B36","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41587-022-01353-8","article-title":"Genome-wide mapping of somatic mutation rates uncovers drivers of cancer","volume":"40","author":"Sherman","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2024090414000972700_btae384-B37","doi-asserted-by":"crossref","first-page":"bbab548","DOI":"10.1093\/bib\/bbab548","article-title":"Comprehensive evaluation of computational methods for predicting cancer driver genes","volume":"23","author":"Shi","year":"2022","journal-title":"Brief Bioinform"},{"key":"2024090414000972700_btae384-B38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC cancer gene census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2024090414000972700_btae384-B39","first-page":"1","article-title":"Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology","volume":"5","author":"van Belzen","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"2024090414000972700_btae384-B40","doi-asserted-by":"crossref","first-page":"29445","DOI":"10.18632\/oncotarget.25655","article-title":"MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III Colon cancer","volume":"9","author":"van den Broek","year":"2018","journal-title":"Oncotarget"},{"key":"2024090414000972700_btae384-B41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng.491","article-title":"Somatic mutations of the Parkinson\u2019s disease\u2013associated gene PARK2 in glioblastoma and other human malignancies","volume":"42","author":"Veeriah","year":"2010","journal-title":"Nat Genet"},{"key":"2024090414000972700_btae384-B42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2018.03.046","article-title":"Machine learning detects pan-cancer Ras pathway activation in The Cancer Genome Atlas","volume":"23","author":"Way","year":"2018","journal-title":"Cell Rep"},{"key":"2024090414000972700_btae384-B43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"2024090414000972700_btae384-B44","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1078-0432.CCR-13-3140","article-title":"KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF\u2013wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)","volume":"20","author":"Yoon","year":"2014","journal-title":"Clin Cancer Res"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/40\/Supplement_2\/ii37\/59017019\/btae384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/40\/Supplement_2\/ii37\/59017019\/btae384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:46:06Z","timestamp":1725522366000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/40\/Supplement_2\/ii37\/7749081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":44,"journal-issue":{"issue":"Supplement_2","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btae384","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,9,1]]}}}